Lowest Price Guaranteed
Slides
236
Last Updated
September 2025
View Count
16448
SECTION I: REPORT OVERVIEW
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
SECTION II: QUALITATIVE INSIGHTS
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Healthcare Analytics
6.2.1. Key Characteristics of Healthcare Analytics
6.2.2. Key Applications of the Healthcare Analytics
6.2.3. Challenges Associated with Healthcare Analytics
6.3. Future Perspective
7. REGULATORY SCENARIO
SECTION III: MARKET OVERVIEW
8. COMPREHENSIVE DATABASE OF LEADING PLAYERS
9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. Healthcare Analytics: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. Healthcare Analytics: Overall Market Landscape
9.2.4.1. Analysis by Analysis Type
9.2.4.2. Analysis by Component Type
9.2.4.3. Analysis by Delivery Mode Type
9.2.4.4. Analysis by Application Type
9.2.4.5. Analysis by End User
10. PORTER'S FIVE FORCES ANALYSIS
11. COMPETITIVE COMPETITIVENESS ANALYSIS
12. STARTUP ECOSYSTEM IN THE HEALTHCARE ANALYTICS MARKET
12.1. Healthcare Analytics: Market Landscape of Startups
12.1.1. Analysis by Year of Establishment
12.1.2. Analysis by Company Size
12.1.3. Analysis by Company Size and Year of Establishment
12.1.4. Analysis by Location of Headquarters
12.1.5. Analysis by Company Size and Location of Headquarters
12.1.6. Analysis by Ownership Structure
12.2. Key Findings
SECTION IV: COMPANY PROFILES
13. COMPANY PROFILES
13.1. Chapter Overview
13.2. Allscripts Healthcare Solutions
13.2.1. Company Overview
13.2.2. Company Mission
13.2.3. Company Footprint
13.2.4. Management Team
13.2.5. Contact Details
13.2.6. Financial Performance
13.2.7. Operating Business Segments
13.2.8. Service / Product Portfolio (project specific)
13.2.9. MOAT Analysis
13.2.10. Recent Developments and Future Outlook
* similar detail is presented for other below mentioned companies based on information in the public domain
13.3. Cerner
13.4. Elsevier
13.5. IBM
13.6. IQVIA
13.7. McKesson
13.8. Medeanalytics
13.9. Optum
13.10. Oracle
13.11. SAS Institute
13.12. Truven Health Analytics
13.13. Verisk Analytics
SECTION V: MARKET TRENDS
14. PATENT ANALYSIS
14.1. Chapter Overview
14.2. Scope and Methodology
14.3. Healthcare Analytics: Patent Analysis
14.3.1. Analysis by Patent Publication Year
14.3.2. Analysis by Type of Patent and Patent Publication Year
14.3.3. Analysis by Patent Application Year
14.3.4. Analysis by Patent Jurisdiction
14.3.5. Analysis by CPC Symbols
14.3.6. Analysis by Type of Applicant
14.3.7. Leading Industry Players: Analysis by Number of Patents
14.3.8. Leading Individual Assignees: Analysis by Number of Patents
15. PARTNERSHIPS AND COLLABORATIONS
15.1. Chapter Overview
15.2. Partnership Models
15.3. Healthcare Analytics: Partnerships and Collaborations
15.3.1. Analysis by Year of Partnership
15.3.2. Analysis by Type of Partnership
15.3.3. Analysis by Year and Type of Partnership
15.3.4. Analysis by Type of Partner
15.3.5. Analysis by Location of Headquarters of Partner
15.3.6. Analysis by Type of Partnership and Location of Headquarters of Partner
15.3.7. Most Active Players: Analysis by Number of Partnerships
15.3.8. Regional Analysis
15.3.8.1. Intercontinental and Intracontinental Deals
15.3.8.2. Local and International Deals
SECTION VI: MARKET OPPORTUNITY ANALYSIS
16. GLOBAL HEALTHCARE ANALYTICS MARKET
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Trends Disruption Impacting Market
16.4. Demand Side Trends
16.5. Supply Side Trends
16.6. Global Healthcare Analytics Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. Multivariate Scenario Analysis
16.7.1. Conservative Scenario
16.7.2. Optimistic Scenario
16.8. Investment Feasibility Index
16.9. Key Market Segmentations
17. MARKET OPPORTUNITIES BASED ON TYPE OF ANALYSIS
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Healthcare Analytics Market for Descriptive Analysis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. Healthcare Analytics Market for Predictive Analysis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.8. Healthcare Analytics Market for Prescriptive Analysis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.9. Healthcare Analytics Market for Other Types of Healthcare Analysis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.10. Data Triangulation and Validation
17.10.1. Secondary Sources
17.10.2. Primary Sources
17.10.3. Statistical Modeling
18. MARKET OPPORTUNITIES BASED ON TYPE OF COMPONENT
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Healthcare Analytics Market for Software: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. Healthcare Analytics Market for Services: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.8. Data Triangulation and Validation
18.8.1. Secondary Sources
18.8.2. Primary Sources
18.8.3. Statistical Modeling
19. MARKET OPPORTUNITIES BASED ON TYPE OF DELIVERY MODE
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. Healthcare Analytics Market for On-Premises: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7. Healthcare Analytics Market for Web-Based: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.8. Healthcare Analytics Market for Cloud-Based: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.9. Data Triangulation and Validation
19.9.1. Secondary Sources
19.9.2. Primary Sources
19.9.3. Statistical Modeling
20. MARKET OPPORTUNITIES BASED ON TYPE OF APPLICATION
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. Healthcare Analytics Market for Clinical: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.7. Healthcare Analytics Market for Financial: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.8. Healthcare Analytics Market for Operational: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.9. Healthcare Analytics Market for Administrative: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.10. Data Triangulation and Validation
20.10.1. Secondary Sources
20.10.2. Primary Sources
20.10.3. Statistical Modeling
21. MARKET OPPORTUNITIES BASED ON END USER
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix
21.6. Healthcare Analytics Market for Healthcare Payers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.7. Healthcare Analytics Market for Healthcare Providers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.8. Data Triangulation and Validation
21.8.1. Secondary Sources
21.8.2. Primary Sources
21.8.3. Statistical Modeling
22. MARKET OPPORTUNITIES FOR HEALTHCARE ANALYTICS IN NORTH AMERICA
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix
22.6. Healthcare Analytics Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.1. Healthcare Analytics Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.2. Healthcare Analytics Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.3. Healthcare Analytics Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.7. Data Triangulation and Validation
23. MARKET OPPORTUNITIES FOR HEALTHCARE ANALYTICS IN EUROPE
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix
23.6. Healthcare Analytics Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.1. Healthcare Analytics Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.2. Healthcare Analytics Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.3. Healthcare Analytics Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.4. Healthcare Analytics Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.5. Healthcare Analytics Market in The UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.6. Healthcare Analytics Market in Rest of the Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.7. Data Triangulation and Validation
24. MARKET OPPORTUNITIES FOR HEALTHCARE ANALYTICS IN ASIA-PACIFIC
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix
24.6. Healthcare Analytics Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.1. Healthcare Analytics Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.2. Healthcare Analytics Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.3. Healthcare Analytics Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.4. Healthcare Analytics Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.5. Healthcare Analytics Market in Australia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.6. Healthcare Analytics Market in Russia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.7. Healthcare Analytics Market in Thailand: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.8. Healthcare Analytics Market in Malaysia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.9. Healthcare Analytics Market in Indonesia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.10. Healthcare Analytics Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.7. Data Triangulation and Validation
25. MARKET OPPORTUNITIES FOR HEALTHCARE ANALYTICS IN MIDDLE EAST AND NORTH AFRICA (MENA)
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Revenue Shift Analysis
25.4. Market Movement Analysis
25.5. Penetration-Growth (P-G) Matrix
25.6. Healthcare Analytics Market in Middle East and North Africa (MENA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.1. Healthcare Analytics Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 205)
25.6.2. Healthcare Analytics Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.3. Healthcare Analytics Market in United Araba Emirates: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.7. Data Triangulation and Validation
26. MARKET OPPORTUNITIES FOR HEALTHCARE ANALYTICS IN LATIN AMERICA
26.1. Chapter Overview
26.2. Key Assumptions and Methodology
26.3. Revenue Shift Analysis
26.4. Market Movement Analysis
26.5. Penetration-Growth (P-G) Matrix
26.6. Healthcare Analytics Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.1. Healthcare Analytics Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.2. Healthcare Analytics Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.3. Healthcare Analytics Market in Rest of Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.7. Data Triangulation and Validation
27. ADJACENT MARKET ANALYSIS
SECTION VII: STRATEGIC TOOLS
28. KEY WINNING STRATEGIES
29. VALUE CHAIN ANALYSIS
30. ROOTS STRATEGIC RECOMMENDATIONS
SECTION VIII: OTHER EXCLUSIVE INSIGHTS
31. INSIGHTS FROM PRIMARY RESEARCH
32. REPORT CONCLUSION
SECTION IX: APPENDIX
33. TABULATED DATA
34. LIST OF COMPANIES AND ORGANIZATIONS
35. CUSTOMIZATION OPPORTUNITIES
36. ROOTS SUBSCRIPTION SERVICES
37. AUTHOR DETAILS